News
Traditional lab tests for blood-borne pathogens can take days to yield results. Karius has developed a liquid biopsy test based on metagenomic sequencing and machine-learning analysis of microbial cell-free DNA in the blood, allowing the company to detect over 1,000 pathogens from a single blood draw in just one day. Doctors are already using the Karius tests to detect infections in immunocompromised patients, and it can also be used to help drug researchers identify the right subjects for clinical trials and control infection-related side effects.
News & Insights
Explore Companies
Valar Labs
Using AI models trained on digital pathology images to help oncologists make smarter cancer treatment decisions
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Noetik
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Remedy Robotics
Vascular intervention without borders